Grants and Contributions:
Title:
Nitric Oxide Releasing Solution (NORS) Securement Device - Initial Design
Agreement Number:
914826
Agreement Value:
$33,200.00
Agreement Date:
Oct 2, 2018 - Mar 15, 2019
Description:
The Firm has developed a patented, antimicrobial nitric oxide releasing solution (NORS), with demonstrated anti-fungal activities. The Firm seeks to develop a device for longer term/slow delivery of NORS, for treatment of skin infections.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
North Vancouver, British Columbia, CA V7H 2Y4
Reference Number:
172-2018-2019-Q3-914826
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
710549726
Recipient Type:
For-profit organization
Recipient's Legal Name:
Sanotize Research & Development Corp.
Federal Riding Name:
Burnaby North--Seymour
Federal Riding Number:
59002
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710